Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids


    loading  Checking for direct PDF access through Ovid

Abstract

AimsTo evaluate the effect of corticosteroids on tacrolimus pharmacokinetics.MethodsIn a randomized trial, kidney transplant recipients were treated with tacrolimus and mycophenolate mofetil with either daclizumab (n = 31) or 3 months of prednisone (n = 34). Tacrolimus dose-adjusted predose concentrations (C0) at month 1-6 were compared between both groups and within the corticosteroid group before and after prednisone withdrawal.ResultsAt month 1 the tacrolimus dose-adjusted C0 in the corticosteroid group was 83 ± 8 vs 119 ± 17 ng ml−1 mg−1 kg−1 in the daclizumab group. The tacrolimus doseadjusted C0 within the corticosteroid group at month 1 and 2 was 42% and 29% lower compared with month 4 (P < 0.001).ConclusionsA higher tacrolimus dose is required to reach target concentrations when used in combination with corticosteroids.

    loading  Loading Related Articles